Insiders · EVH

David Farner

Director at Evolent Health, Inc. (EVH)

David Farner has filed 2 insider reports with the SEC since June 2021, as director at Evolent Health, Inc. (EVH). The latest filing, on June 13, 2022, reports grant or award at Evolent Health, Inc. (EVH).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where David Farner is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
EVH Evolent Health, Inc.Director67,091$4.71Jun 13, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David Farner with

Other insiders at the same companies

Questions about David Farner

What is David Farner's role at Evolent Health, Inc.?
David Farner reports to the SEC as director at Evolent Health, Inc. (EVH), according to the latest filing on June 13, 2022.
How many shares does David Farner own?
After the latest filing that states it, David Farner directly owned 67,091 shares of Evolent Health, Inc. (EVH). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Farner bought or sold stock recently?
No open-market purchases or sales by David Farner are on file. The filings report grant or award.
How do I get alerts when David Farner files?
Follow David Farner on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Farner (SEC CIK 0001642786). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR